Singapore markets open in 4 hours 22 minutes

Takeda Pharmaceutical Company Limited (TAK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
14.07-0.10 (-0.71%)
As of 03:38PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close14.17
Bid14.08 x 4000
Ask14.09 x 3000
Day's range14.01 - 14.12
52-week range13.19 - 17.15
Avg. volume1,871,853
Market cap44.186B
Beta (5Y monthly)0.64
PE ratio (TTM)34.32
Earnings dateN/A
Forward dividend & yield0.66 (4.23%)
Ex-dividend date29 Sept 2022
1y target estN/A
  • Zacks

    Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Reuters

    UPDATE 2-Takeda Pharma gets US FDA approval for rare blood disorder therapy

    The U.S. Food and Drug Administration on Thursday approved Takeda Pharmaceutical's therapy to treat a rare genetic blood disorder in adult and pediatric patients. Takeda's Adzynma becomes the first treatment available to patients with congenital thrombotic thrombocytopenic purpura (TTP). Congenital TTP is a life-threatening, rare genetic disorder with debilitating chronic symptoms.

  • Insider Monkey

    Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2023 Earnings Call Transcript

    Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2023 Earnings Call Transcript October 27, 2023 Christopher O’Reilly: Thank you very much for joining us out of your busy schedule today for the earnings call for Second Quarter Fiscal 2023 with Takeda Pharmaceutical Company Limited. I am going to be the moderator today O’Reilly, the Head of IR. […]